ARCHIVES

New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet,

This article is from The Cancer Letter archive.

Vol. 33 No. 02 | January 19, 2007

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Concepts For New CTEP, RRP Grants

February 24, 1989

AVEO’s Tizozanib Fails in Colorectal Cancer

January 10, 2014

Spectral Mammography “Like Color vs. Black & White TV”

August 31, 2012

NCAB To Consider Fate Of Existing Two Proposed Comp Center At Important Meeting

April 28, 1978

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

July 27, 2012

RFP Suggestions For Immunodiagnosis Research Offered

October 22, 1976